webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Boc-Gly-Gly-Phe-Gly-OH (TFA)

  CAS No.: 2450273-39-7   Cat No.: BADC-01711 4.5  

Boc-Gly-Gly-Phe-Gly-OH is a peptide-based ADC linker precursor enabling protease-sensitive payload release for precise antibody-drug conjugate activity in tumor cells.

Boc-Gly-Gly-Phe-Gly-OH (TFA)

Structure of 2450273-39-7

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C22H29F3N4O9
Molecular Weight
550.48

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(tert-Butoxycarbonyl)glycylglycyl-L-phenylalanylglycine 2,2,2-trifluoroacetic acid salt
IUPAC Name
2-[[(2S)-2-[[2-[[2-[(2-methylpropan-2-yl)oxycarbonylamino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]acetic acid;2,2,2-trifluoroacetic acid
Canonical SMILES
CC(C)(C)OC(=O)NCC(=O)NCC(=O)NC(CC1=CC=CC=C1)C(=O)NCC(=O)O.C(=O)(C(F)(F)F)O
InChI
InChI=1S/C20H28N4O7.C2HF3O2/c1-20(2,3)31-19(30)23-10-15(25)21-11-16(26)24-14(18(29)22-12-17(27)28)9-13-7-5-4-6-8-13;3-2(4,5)1(6)7/h4-8,14H,9-12H2,1-3H3,(H,21,25)(H,22,29)(H,23,30)(H,24,26)(H,27,28);(H,6,7)/t14-;/m0./s1
InChIKey
RXCXUMYQOKOAGZ-UQKRIMTDSA-N

Boc-Gly-Gly-Phe-Gly-OH (TFA) is a protected peptide widely utilized in bioscience research and pharmaceutical manufacturing. Here are four key applications of Boc-Gly-Gly-Phe-Gly-OH (TFA) presented with high perplexity and burstiness:

Peptide Synthesis: Acting as a crucial building block in peptide and protein synthesis, Boc-Gly-Gly-Phe-Gly-OH (TFA) plays a pivotal role. Its Boc protecting group enables selective reactions with other amino acids, preventing premature interactions. This mechanism facilitates the efficient assembly of peptides, ensuring high purity and yield levels.

Drug Development: Within the realm of pharmaceutical exploration, Boc-Gly-Gly-Phe-Gly-OH (TFA) contributes significantly to the creation of peptide-based drug candidates. Researchers leverage this peptide to investigate drug-receptor interactions and assess the therapeutic potential of novel medications. Its well-defined structure positions it as an ideal candidate for conducting structure-activity relationship studies in drug development.

Enzyme Substrate Studies: Frequently utilized as a substrate in enzymatic assays, Boc-Gly-Gly-Phe-Gly-OH (TFA) enables scientists to delve into the activities and specificities of proteolytic enzymes. Through monitoring how enzymes cleave this peptide, valuable insights into enzyme kinetics and mechanisms are garnered. This knowledge serves as a cornerstone for designing enzyme inhibitors and therapeutic interventions.

Structural Biology: In the domain of structural biology, Boc-Gly-Gly-Phe-Gly-OH (TFA) finds application in constructing peptide models for X-ray crystallography and NMR studies. These models aid scientists in deciphering the three-dimensional structures and folding mechanisms of proteins. Accurate structural data is indispensable for rational drug design and unraveling protein functionalities at a molecular level.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Boc-Gly-Gly-Phe-Gly-OH (TFA)
Send Inquiry
Verification code
Inquiry Basket